BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 18504744)

  • 1. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hepatic tumor detection with ferumoxide-enhanced magnetic resonance imaging: is chemical-shift-selective fat suppression necessary for fast spin-echo sequence?
    Goshima S; Kanematsu M; Matsuo M; Kondo H; Kako N; Yokoyama R; Hoshi H; Moriyama N
    J Magn Reson Imaging; 2004 Jul; 20(1):75-82. PubMed ID: 15221811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of malignant hepatic tumors with ferumoxide-enhanced MR imaging: usefulness of multishot and single-shot fast spin echo sequences.
    Goshima S; Kanematsu M; Matsuo M; Murakami T; Hori M; Takamura M; Kondo H; Kako N; Moriyama N; Nakamura H; Hoshi H
    Magn Reson Imaging; 2004 Apr; 22(3):379-88. PubMed ID: 15062933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs.
    Matsuo M; Kanematsu M; Itoh K; Murakami T; Maetani Y; Kondo H; Goshima S; Kako N; Hoshi H; Konishi J; Moriyama N; Nakamura H
    AJR Am J Roentgenol; 2004 Jan; 182(1):235-42. PubMed ID: 14684545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.
    Kim SH; Choi D; Lim JH; Lee WJ; Jang HJ; Lim HK; Lee SJ; Cho JM; Kim SK; Kim GC
    Korean J Radiol; 2002; 3(2):87-97. PubMed ID: 12087198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
    Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
    J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences.
    Kim SH; Choi D; Lim HK; Kim MJ; Jang KM; Kim SH; Lee WJ; Lee J; Jeon YH; Lim JH
    Eur J Radiol; 2006 Sep; 59(3):413-23. PubMed ID: 16678373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Korean J Radiol; 2008; 9(6):510-9. PubMed ID: 19039267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging.
    Van Beers BE; Lacrosse M; Jamart J; Grandin C; Gigot JF; Horsmans Y; Demeure R; Pringot J
    AJR Am J Roentgenol; 1997 Mar; 168(3):713-7. PubMed ID: 9057521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions.
    Yoshikawa T; Mitchell DG; Hirota S; Ohno Y; Oda K; Maeda T; Fujii M; Sugimura K
    J Magn Reson Imaging; 2006 May; 23(5):712-9. PubMed ID: 16568431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.
    Kanematsu M; Itoh K; Matsuo M; Maetani Y; Ametani F; Kondo H; Kato H; Hoshi H
    J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of small (Tonan T; Fujimoto K; Azuma S; Ono N; Matsushita S; Kojiro M; Hayabuchi N
    Eur J Radiol; 2007 Oct; 64(1):133-9. PubMed ID: 17408900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.
    Fukukura Y; Kamiyama T; Takumi K; Shindo T; Higashi R; Nakajo M
    J Magn Reson Imaging; 2010 Mar; 31(3):607-16. PubMed ID: 20187203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions.
    Kim MJ; Kim JH; Choi JY; Park SH; Chung JJ; Kim KW; Mitchell DG
    AJR Am J Roentgenol; 2006 Sep; 187(3):W255-66. PubMed ID: 16928903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.